Vaxart

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Vaxart and buy or sell other stocks, ETFs, and their options commission-free!

About VXRT

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. 

CEO
Steven Lo
CEOSteven Lo
Employees
115
Employees115
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2004
Founded2004
Employees
115
Employees115

VXRT Key Statistics

Market cap
80.12M
Market cap80.12M
Price-Earnings ratio
-1.44
Price-Earnings ratio-1.44
Dividend yield
Dividend yield
Average volume
497.27K
Average volume497.27K
High today
$0.367
High today$0.367
Low today
$0.3402
Low today$0.3402
Open price
$0.3402
Open price$0.3402
Volume
337.02K
Volume337.02K
52 Week high
$1.07
52 Week high$1.07
52 Week low
$0.2606
52 Week low$0.2606

VXRT News

TipRanks 21h
Vaxart Discusses Reverse Stock Split Proposal

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own VXRT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.